Here's the live share price of Zydus Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Zydus Lifesciences has gained 13.38% CAGR. Over the past year, the corresponding return has been -4.87%.
Zydus Lifesciences’s current P/E of 18.75x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
| Gland Pharma | -0.47 | -8.08 | -16.69 | -6.80 | -7.50 | 1.34 | -7.35 |
Over the last one year, Zydus Lifesciences has declined 4.87% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Zydus Lifesciences has outperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 916.83 | 921.7 |
| 10 | 920.05 | 922.24 |
| 20 | 927.68 | 927.2 |
| 50 | 951.83 | 945.34 |
| 100 | 974.42 | 957.45 |
| 200 | 948.36 | 960.28 |
In the latest quarter, Zydus Lifesciences remained same as its previous close in promoter holding, while DII stake decreased to 10.86%, FII holding rose to 7.34%, and public shareholding moved up to 6.81% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,74,05,149 | 1.26 | 1,640.44 | |
| 1,05,00,000 | 1.74 | 989.63 | |
| 32,28,172 | 0.39 | 304.26 | |
| 17,94,293 | 0.5 | 169.11 | |
| 17,61,233 | 2.57 | 166 | |
| 8,02,102 | 1.29 | 75.6 | |
| 5,00,000 | 0.72 | 47.13 | |
| 4,32,772 | 0.31 | 40.79 | |
| 3,50,984 | 0.11 | 33.08 | |
| 2,68,005 | 2.8 | 25.26 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Dec 24, 2025, 11:28 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| Dec 23, 2025, 11:59 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Dec 19, 2025, 3:22 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Dec 16, 2025, 10:52 PM IST | Zydus Lifesciences - Intimation Of ESG Rating |
| Dec 16, 2025, 12:00 AM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 15116.30 Cr. and Equity Capital is Rs. 100.60 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Zydus Lifesciences is ₹917.45 as on Dec 24, 2025.
The Zydus Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Zydus Lifesciences is ₹92,316.94 Cr as on Dec 24, 2025.
Today’s highest and lowest price of Zydus Lifesciences are ₹937.95 and ₹915.30.
The 52-week high/low is the highest and lowest price at which Zydus Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Zydus Lifesciences is ₹1,059.00 and 52-week low of Zydus Lifesciences is ₹797.05 as on Dec 24, 2025.
The Zydus Lifesciences has shown returns of -1.15% over the past day, -0.99% for the past month, -11.37% over 3 months, -4.87% over 1 year, 29.7% across 3 years, and 13.38% over 5 years.
P/E ratio of and PB ratio of Zydus Lifesciences are 18.75 and 3.65 on Dec 24, 2025. While the company gives a dividend yield of 1.20 per annum.